It’s estimated that around one-and-a-half million instrumented spinal procedures will be performed in the United States in 2023-20241; while trauma injuries account for three million non-fatal injuries per year2. Continued innovation clearly holds the key to improving the efficiency and accuracy of treatments; and this is why our biomaterials experts are working closer than ever with our partners to increase the strength, ease-of-use and wear resistance of bone graft substitutes used in orthopedic implants.
1. iData Research, 2023, 2. The American Association for the Surgery of Trauma
30+ years of experience in developing orthopedic solutions.
Every second a patient receives a medical device containing a DSM Biomedical solution.
25 FDA Material Master Files available to support regulatory submissions.
We see a market that recognizes the potential for new materials to help solve some of its greatest challenges. For example, preventing the need for implant removals in trauma applications has huge possibilities for both patients and medical providers. However, achieving this requires biocompatible materials that are proven to perform safely - and can reliably degrade slowly over time as the patient heals.
Another key trend is the demand from surgeons for improved handling abilities of bone grafts, which can best be achieved through new materials that give them increased versatility in the OR – as well as the osteoconductive properties needed to ensure predictable fusions. Today, our experts are working to address all of these challenges (and more).
Our experts draw on a broad biomaterial portfolio to support the body’s natural healing response and potentially improve patient outcomes in spinal, trauma and chondromyxoid fibroma applications. These biocompatible materials can be fine-tuned and customized based on your unique application needs.
Our bioinductive and trimmable bone graft substitutes support bone regeneration in your orthopedic devices – while minimizing the risk of donor-site morbidity and infections for patients. For example, our injectable, biomimetic ceramic putties deliver bone graft material precisely to promote fusion and stimulate osteogenesis.
We also offer arthroscopically injectable bone void fillers; as well as highly durable spacers and load-bearing materials in the form of our biocompatible medical polyurethanes. They help support joints and the spine while reducing adverse reactions in patients during surgery.
Here, our drillable bone void fillers enable accurate and tailored bone healing during orthopedic surgery.
We are proud to offer you a portfolio of customizable, combinable, and sustainable biomaterials that is unrivaled in the medical industry.
At DSM Biomedical we’ve built a wealth of knowledge in trauma and fusion.
Looking for more information on how our orthopedic biomaterials can help you tackle unmet needs?
Discover how we can partner with you to create new solutions for trauma and fusion that can improve patient care.
Our orthopedic experts are here to help.